Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The HA modification enables CD44-mediated targeting of tumor cells, while the ZIF-8 framework provides pH-responsive drug release within the acidic TME
However, these side effects are temporary and will subside quickly
A provider may suggest adjusting your dose or using over-the-counter aids to help manage the transition
Jinhua Li, [email protected] These authors have contributed equally to this work ORCID: Jinhua Li, orcid.org/0000-0003-0085-9168 Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
US$ 29.82
US$ 26.43
US$ 24.10
US$ 24.75
